These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1637339)

  • 21. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
    Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
    J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
    Fujibayashi S; Wenger DA
    Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation.
    Hulková H; Cervenková M; Ledvinová J; Tochácková M; Hrebícek M; Poupetová H; Befekadu A; Berná L; Paton BC; Harzer K; Böör A; Smíd F; Elleder M
    Hum Mol Genet; 2001 Apr; 10(9):927-40. PubMed ID: 11309366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
    Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
    Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.
    Schlote W; Harzer K; Christomanou H; Paton BC; Kustermann-Kuhn B; Schmid B; Seeger J; Beudt U; Schuster I; Langenbeck U
    Eur J Pediatr; 1991 Jun; 150(8):584-91. PubMed ID: 1683286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
    Sandhoff K; Kolter T
    Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting.
    Vaccaro AM; Motta M; Tatti M; Scarpa S; Masuelli L; Bhat M; Vanier MT; Tylki-Szymanska A; Salvioli R
    Hum Mol Genet; 2010 Aug; 19(15):2987-97. PubMed ID: 20484222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
    Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
    Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
    Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lysosomal enzymes, sphingolipid activator proteins, and protective protein].
    Suzuki Y
    Nihon Rinsho; 1995 Dec; 53(12):2887-91. PubMed ID: 8577030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system.
    Kase R; Bierfreund U; Klein A; Kolter T; Itoh K; Suzuki M; Hashimoto Y; Sandhoff K; Sakuraba H
    FEBS Lett; 1996 Sep; 393(1):74-6. PubMed ID: 8804427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure of the lysosomal sphingolipid activator protein 1 by homology with influenza virus neuraminidase.
    Potier M
    Biochem Biophys Res Commun; 1988 Aug; 155(1):32-7. PubMed ID: 3415686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceramide accumulation is associated with increased apoptotic cell death in cultured fibroblasts of sphingolipid activator protein-deficient mouse but not in fibroblasts of patients with Farber disease.
    Tohyama J; Oya Y; Ezoe T; Vanier MT; Nakayasu H; Fujita N; Suzuki K
    J Inherit Metab Dis; 1999 Jun; 22(5):649-62. PubMed ID: 10399097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of human saposin B sphingolipid-binding specificity by alternative splicing. A study with saposin B-derived synthetic peptides.
    Lamontagne S; Potier M
    J Biol Chem; 1994 Aug; 269(32):20528-32. PubMed ID: 8051151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside.
    Hiraiwa M; Martin BM; Kishimoto Y; Conner GE; Tsuji S; O'Brien JS
    Arch Biochem Biophys; 1997 May; 341(1):17-24. PubMed ID: 9143348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of saposin proteins (sphingolipid activator proteins) in lysosomal storage and other diseases.
    Morimoto S; Yamamoto Y; O'Brien JS; Kishimoto Y
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3493-7. PubMed ID: 2110365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.
    Henseler M; Klein A; Reber M; Vanier MT; Landrieu P; Sandhoff K
    Am J Hum Genet; 1996 Jan; 58(1):65-74. PubMed ID: 8554069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.
    Callahan JW
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease.
    Schnabel D; Schröder M; Sandhoff K
    FEBS Lett; 1991 Jun; 284(1):57-9. PubMed ID: 2060627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological study of mice with total deficiency of sphingolipid activator proteins (SAP knockout mice).
    Oya Y; Nakayasu H; Fujita N; Suzuki K; Suzuki K
    Acta Neuropathol; 1998 Jul; 96(1):29-40. PubMed ID: 9678511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.